Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Short Interest Up 171.5% in November

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report) was the target of a significant growth in short interest in November. As of November 15th, there was short interest totalling 103,700 shares, a growth of 171.5% from the October 31st total of 38,200 shares. Based on an average daily volume of 114,300 shares, the days-to-cover ratio is presently 0.9 days.

Analyst Ratings Changes

Separately, Citigroup upgraded Fresenius SE & Co. KGaA to a "strong-buy" rating in a report on Friday, October 25th.

Fresenius SE & Co. KGaA Stock Performance

FSNUY stock traded up $0.12 during mid-day trading on Thursday, reaching $8.83. 35,930 shares of the stock traded hands, compared to its average volume of 50,598. The firm has a market capitalization of $19.73 billion, a PE ratio of 11.70 and a beta of 1.05. The business has a 50-day moving average of $9.12 and a two-hundred day moving average of $8.64. Fresenius SE & Co. KGaA has a 52 week low of $6.57 and a 52 week high of $9.78. The company has a quick ratio of 1.00, a current ratio of 1.29 and a debt-to-equity ratio of 0.56.

About Fresenius SE & Co. KGaA

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.